Chemotherapeutic drugs in pregnancy

被引：71
作者：
Leslie, KK [1 ]
Koil, C [1 ]
Rayburn, WF [1 ]
机构：
[1] Univ New Mexico, Hlth Sci Ctr, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA
来源：
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2005年 / 32卷 / 04期
关键词：
D O I：
10.1016/j.ogc.2005.08.009
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Chemotherapy may be indicated for the treatment of cancer during pregnancy. The decision to use chemotherapy significantly impacts the pregnancy, and in turn the pregnancy may affect the treatment options available to patients with cancer. This review provides information about the effects of chemotherapeutic agents in pregnancy, taking into account both the mother and the fetus. For convenience, the agents are divided into categories based upon class and mechanism of action. These include alkylating agents, antimetabolites, nucleoside analogs, topoisomerase 1 inhibitors, topisomerase 11 inhibitors, vinca alkaloids, taxanes, and biologics such as signaling and growth factor blocking agents.
引用
收藏
页码：627 / +
页数：15
相关论文
共 61 条
[1]   MYELOSCHISIS IN A 6 WEEKS EMBRYO OF A LEUKEMIC WOMAN TREATED BY BUSULFAN [J].
ABRAMOVICI, A ;
SHAKLAI, M ;
PINKHAS, J .
TERATOLOGY, 1978, 18 (02) :241-245
[2]  
BORNSTEIN RS, 1971, CANCER RES, V31, P2004
[3]  
BULLER RE, 1992, OBSTET GYNECOL, V79, P887
[4]   CHLORAMBUCIL TREATMENT IN MINIMAL LESION NEPHROTIC SYNDROME - A REAPPRAISAL OF ITS GONADAL TOXICITY [J].
CALLIS, L ;
NIETO, J ;
VILA, A ;
RENDE, J .
JOURNAL OF PEDIATRICS, 1980, 97 (04) :653-656
[5]   UROGENITAL ANOMALIES IN FETAL RATS PRODUCED BY ANTICANCER AGENT 4(5)-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE [J].
CHAUBE, S ;
SWINYARD, CA .
ANATOMICAL RECORD, 1976, 186 (03) :461-469
[6]  
DEVRIES EGE, 1989, LANCET, V1, P497, DOI 10.1016/S0140-6736(89)91396-2
[7]  
DIAMOND I, 1960, PEDIATRICS, V25, P85
[8]   Chemotherapy for metastatic melanoma during pregnancy [J].
Dipaola, RS ;
Goodin, S ;
Ratzell, M ;
Florczyk, M ;
Karp, G ;
Ravikumar, TS .
GYNECOLOGIC ONCOLOGY, 1997, 66 (03) :526-530
[9]  
DOBBING J, 1977, LANCET, V1, P1155
[10]  
EGAN PC, 1985, CANCER TREAT REP, V69, P1387
1234567